Pharmaceutical Accountability Foundation

Pharmaceutical Accountability Foundation

Striving for equal access to medicines and medical technologies

Access to medicines is a human right

At Pharmaceutical Accountability Foundation, we believe the pharmaceutical industry has to be held accountable when they limit needed access by raising prices to unsustainable levels in pursuit of unfair profits. We therefore investigate cases of pharmaceutical company abuse of market exclusivity rights to keep prices high at the expense of public health. We then work to inform the public, or take legal action if necessary.

Issues

Why is medical technology so very expensive? There are many issues in the way we currently incentivise innovation.

Solutions

There are several legal and policy solutions to stop misconduct, high prices, and limited access to medicines.

Cases

Examples of excessive pricing we have marked for investigation, or find illustrative of systemic challenges.

Recent News

Why the VIG code of conduct fails to put health first

***original publicationdate 30-7-2020, but because of recent developments republished*** Robin Veenman (former research intern at Wemos and Pharmaceutical Accountability Foundation & master student Political Science at the...

The Pharmaceutical Accountability Foundation scores pharmaceutical companies’ behaviour regarding Covid-19 in a GCCP Scorecard. Conclusion: Big differences in adherence to human rights principles

Bergeijk, 22 January 2021 – Pharmaceutical Accountability Foundation  (PAF) publishes a GCCP scorecard of pharmaceutical companies that develop important vaccines and pharmaceuticals for the Corona...

Historic victory in the case of health insurance company Menzis against the pharmaceutical company AstraZeneca

The Dutch District Court of The Hague has issued a historic and ground breaking judgement in the case of health insurance company Menzis against the...

Webinar: Covid-19: Future of pharmaceuticals.

Ellen 't Hoen - member of the advisory board talks in a webinar about the possible future of medicines and vaccines concerning Covid-19. Please watch...

Recent Tweets

💉Het delen v patenten voor vaccins is een hot item. Wat vinden @attjekuiken (@PvdA), Noortje Thijssen (@groenlinks), @JobaCDA(@cdavandaag), @Vera_Bergkamp(@D66) & @mirjambikker (@christenunie) hiervan? Volg het #Geneesmiddelendebat live op 25feb om 20:00! https://buff.ly/37uSRBi

🤯@Pfizer will make $15 billion from Covid-19 vaccines sales in 2021
🌍They refuse to share the technology with rest of the world
⛔Pharma companies should not profit from this pandemic at the expense of people’s health
📣The @EU_Commission must act!
SIGN: http://www.noprofitonpandemic.eu

De vaccinperikelen laten zien dat de machtsbalans op de markt voor medicijnen is verstoord. Hoe komen er meer noodzakelijke en betaalbare geneesmiddelen?
https://www.nrc.nl/nieuws/2021/02/12/wat-de-coronavaccins-ons-leren-over-de-markt-voor-geneesmiddelen-a4031606?utm_source=twitter&utm_medium=social&utm_campaign=twitter&utm_term=20210212

Load More...